Skip to Main Content

Author Details

Jay S Wunder
University of Toronto
1990
327
65
PMIDPaper TitleJournal TitlePublished Year
36724203Use of virtual reality for the management of phantom limb pain: a systematic review.Disabil Rehabil2024
36724203Use of virtual reality for the management of phantom limb pain: a systematic review.Disabil Rehabil2024
36243649Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy.Eur J Surg Oncol2023
36243649Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy.Eur J Surg Oncol2023
35377078Management of giant cell tumors of the distal radius: a systematic review and meta-analysis.Eur J Orthop Surg Traumatol2023
35778618T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.Skeletal Radiol2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37781501Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study.Ther Adv Med Oncol2023
36840861A Size-Based Criteria for Flap Reconstruction After Thigh-Adductor, Soft-Tissue Sarcoma Resection.Ann Surg Oncol2023
37466581Open Versus Core Needle Biopsy in Lower-Extremity Sarcoma: Current Practice Patterns and Patient Outcomes.J Bone Joint Surg Am2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
36765897One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study.Cancers (Basel)2023
37267108Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation.Cell Rep2023
37391201Is a radiological score able to predict resection-grade chondrosarcoma in primary intraosseous lesions of the long bones?Bone Joint J2023
37121582Giant cell tumour of bone.Bone Joint J2023
36680529Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors.Genes Chromosomes Cancer2023
36658251Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?Ann Surg Oncol2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37781501Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study.Ther Adv Med Oncol2023
35377078Management of giant cell tumors of the distal radius: a systematic review and meta-analysis.Eur J Orthop Surg Traumatol2023
35778618T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.Skeletal Radiol2023
37391201Is a radiological score able to predict resection-grade chondrosarcoma in primary intraosseous lesions of the long bones?Bone Joint J2023
37121582Giant cell tumour of bone.Bone Joint J2023
37466581Open Versus Core Needle Biopsy in Lower-Extremity Sarcoma: Current Practice Patterns and Patient Outcomes.J Bone Joint Surg Am2023
37267108Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation.Cell Rep2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
36840861A Size-Based Criteria for Flap Reconstruction After Thigh-Adductor, Soft-Tissue Sarcoma Resection.Ann Surg Oncol2023
36680529Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors.Genes Chromosomes Cancer2023
36765897One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study.Cancers (Basel)2023
36658251Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?Ann Surg Oncol2023
34826230Radiological progression of extremity soft tissue sarcoma following pre-operative radiotherapy predicts for poor survival.Br J Radiol2022
35969303ASO Author Reflections: Improving Management Strategies for Patients with Primary Dermatofibrosarcoma Protuberans (DFSP).Ann Surg Oncol2022
35903257Mid and long-term overall survival after carcinologic resections of thyroid cancer bone metastases.Front Surg2022
35565308How Do the Outcomes of Radiation-Associated Pelvic and Sacral Bone Sarcomas Compare to Primary Osteosarcomas following Surgical Resection?Cancers (Basel)2022
35933538Surgical Outcomes of Primary Dermatofibrosarcoma Protuberans: A Retrospective, Multicenter Study.Ann Surg Oncol2022
36056967Lumbopelvic shortening and local host bone-to-host bone reconstruction: a surgical method for lumbopelvic fusion following total sacrectomy.Eur Spine J2022
35540727Automatic Registration and Error Color Maps to Improve Accuracy for Navigated Bone Tumor Surgery Using Intraoperative Cone-Beam CT.JB JS Open Access2022
34969715Preoperative Risk Factors for Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans.Anticancer Res2022
35158816Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma.Cancers (Basel)2022
34826230Radiological progression of extremity soft tissue sarcoma following pre-operative radiotherapy predicts for poor survival.Br J Radiol2022
35540727Automatic Registration and Error Color Maps to Improve Accuracy for Navigated Bone Tumor Surgery Using Intraoperative Cone-Beam CT.JB JS Open Access2022
35565308How Do the Outcomes of Radiation-Associated Pelvic and Sacral Bone Sarcomas Compare to Primary Osteosarcomas following Surgical Resection?Cancers (Basel)2022
35969303ASO Author Reflections: Improving Management Strategies for Patients with Primary Dermatofibrosarcoma Protuberans (DFSP).Ann Surg Oncol2022
35903257Mid and long-term overall survival after carcinologic resections of thyroid cancer bone metastases.Front Surg2022
35933538Surgical Outcomes of Primary Dermatofibrosarcoma Protuberans: A Retrospective, Multicenter Study.Ann Surg Oncol2022
36056967Lumbopelvic shortening and local host bone-to-host bone reconstruction: a surgical method for lumbopelvic fusion following total sacrectomy.Eur Spine J2022
35158816Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma.Cancers (Basel)2022
34969715Preoperative Risk Factors for Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans.Anticancer Res2022
33009490RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors.Mod Pathol2021
33961173Staging and Surveillance of Myxoid Liposarcoma: Follow-up Assessment and the Metastatic Pattern of 169 Patients Suggests Inadequacy of Current Practice Standards.Ann Surg Oncol2021
  • 1 - 50 of 654

Recommended Authors

Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 2011
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 2009
Number of shared co-authors 2
Oslo University Hospital
Career Start Year 2007
Number of shared co-authors 8
University of California-Los Angeles
Career Start Year 2006
Number of shared co-authors 6
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 18
University College London, Cancer Institute
Career Start Year 2003
Number of shared co-authors 22
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
The Johns Hopkins Hospital
Career Start Year 2001
Number of shared co-authors 13
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 0
University of California los angeles
Career Start Year 2001
Number of shared co-authors 10
Tianjin Medical University Cancer Institute and Hospital
Career Start Year 2000
Number of shared co-authors 2
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1999
Number of shared co-authors 4
Schulich School of Medicine & Dentistry, Western University
Career Start Year 1998
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 12
Oregon Health & Science University
Career Start Year 1996
Number of shared co-authors 7
University Hospital of Tours
Career Start Year 1996
Number of shared co-authors 6
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 2
Roswell Park Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 3
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 10
University College London Hospitals NHS Foundation Trust
Career Start Year 1991
Number of shared co-authors 18
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 1
University of California-Los Angeles
Career Start Year 1990
Number of shared co-authors 3
Institut Gustave Roussy
Career Start Year 1985
Number of shared co-authors 8
University Hospitals Birmingham NHS Foundation Trust
Career Start Year 1984
Number of shared co-authors 18
College of Veterinary Medicine and Biomedical Sciences, Colorado State University
Career Start Year 1975
Number of shared co-authors 16
University of California-Los Angeles
Career Start Year 1969
Number of shared co-authors 2

Collaborators

Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 65
University of Toronto
Co-authored papers 49
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 30
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Co-authored papers 26
University Health Network, University of Toronto
Co-authored papers 11
National Cancer Institute
Co-authored papers 10
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 10
Center for Applied Medical Research.
Co-authored papers 10
National Cancer Institute, National Institutes of Health
Co-authored papers 10
Frederick National Laboratory for Cancer Research
Co-authored papers 9
University of Texas MD Anderson Cancer Center
Co-authored papers 9
National Cancer Institute
Co-authored papers 8
Princess Margaret Cancer Centre
Co-authored papers 8
University College London, UCL Cancer Institute
Co-authored papers 8
Keck School of Medicine of the University of Southern California
Co-authored papers 8
National Cancer Institute
Co-authored papers 8
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 8
National Cancer Institute
Co-authored papers 7
University of Navarra, Center for Applied Medical Research
Co-authored papers 7
Mount Sinai Hospital
Co-authored papers 7
Co-authored papers 7
National Cancer Institute, National Institutes of Health
Co-authored papers 7
St Jude Children's Research Hospital
Co-authored papers 7
Clinica Universidad de Navarra
Co-authored papers 6
National Cancer Institute
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 6
University College London, UCL Cancer Institute
Co-authored papers 6
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 6
Spanish National Cancer Research Centre
Co-authored papers 6
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 6